Gains, gains, gains for equities - Thursday Review, July 2

By: Miguel A. Rodriguez

09:45, 14 September 2020

The NFP and the prospects of a COVID-19 vaccine from Pfizer moved the markets.

The US

The positive NFP gave investors hope in an economic recovery, but the fact that yesterday the States reported a record number of infections – 55,000 – made the benchmarks take a step back. Still, they ended on the positive territory: USA30 gained 1.02%, while USA500 rose 1.04%. TECH100 added 1.10%. 

Oil went up 2.1% to $40.65 per barrel, while Brent climbed 2.4% to $43.05.

Gold was just one stone throw away from the $1,800 record it broke at the beginning of the week, as yesterday it traded at $1,790.90.

The Dollar Index slipped 0.05% to 97.248.


Asia and Australia

Japan225 gained 0.44%, erasing Wednesday’s lows caused by a drop of real estate and railway & bus sectors. Yesterday, alongside paper & pulp, shares flew higher. 

Yesterday was the first day when HongKong45 traded under the new security law. It jumped by 1.53%. 

Australia’s ASX went up 1.03%.

USD/JPY was up 0.04% to 107.53.

AUD/USD added 0.09% to 0.6928.

USD/CNY lost 0.01% to 7.0657. 


Europe

The American optimism descended upon European markets too. UK100 closed 1.3% higher, still behind its German and French counterparts. Germany30 rose 2.8%, while France40 climbed 2.5%.

GBP/USD slipped 0.05% to 1.2460.

With our resources and your passion, you can build and improve your strategies! Visit CAPEX.com for more!

Sources: marketwatch.com, investing.com


Share this article

This information prepared by capex.com/za is not an offer or a solicitation for the purpose of purchase or sale of any financial products referred to herein or to enter into any legal relations, nor an advice or a recommendation with respect to such financial products.This information is prepared for general circulation. It does not regard to the specific investment objectives, financial situation, or the particular needs of any recipient.You should independently evaluate each financial product and consider the suitability of such a financial product, by taking into account your specific investment objectives, financial situation, or particular needs, and by consulting an independent financial adviser as needed, before dealing in any financial products mentioned in this document.This information may not be published, circulated, reproduced, or distributed in whole or in part to any other person without the Company’s prior written consent.
Past performance is not always indicative of likely or future performance. Any views or opinions presented are solely those of the author and do not necessarily represent those of capex.com/zaJME Financial Services (Pty) Ltd trading as CAPEX.COM/ZA acts as intermediary between the investor and Magnasale Trading Ltd, the counterparty to the contract for difference purchased by the Investor via CAPEX.COM/ZA, authorised & regulated by the Cyprus Securities and Exchange Commission with license number 264/15.  Magnasale Trading Ltd is the principal to the CFD purchased by investors.